Currently Viewing:
The American Journal of Managed Care April 2010
Estimated Effect of Asthma Case Management Using Propensity Score Methods
Sylvia Brandt, PhD; Sara Gale, MPH; and Ira B. Tager, MD, MPH
Pharmacist Collaborative Management of Poorly Controlled Diabetes Mellitus: A Randomized Controlled Trial
John P. Jameson, PharmD; and Philip J. Baty, MD
Age and Rural Residence Effects on Accessing Colorectal Cancer Treatments: A Registry Study
Jayashri Sankaranarayanan, PhD; Shinobu Watanabe-Galloway, PhD; Junfeng Sun, PhD; Fang Qiu, MS, PhD; Eugene C. Boilesen, BS; and Alan G. Thorson, MD
Currently Reading
Low-Value Services in Value-Based Insurance Design
Peter J. Neumann, ScD; Hannah R. Auerbach, BA; Joshua T. Cohen, PhD; and Dan Greenberg, PhD
Getting the Right Services Covered by Health Insurance
Dean G. Smith, PhD
Relationship Between High Cost Sharing and Adverse Outcomes: A Truism That's Tough to Prove
Niteesh K. Choudhry, MD, PhD
Knowledge of Cost Sharing and Decisions to Seek Care
Amy M. Lischko, DSc; and James F. Burgess Jr, PhD
Economic Evaluation of an Internet-Based Weight Management Program
Rafia S. Rasu, PhD; Christine M. Hunter, PhD; Alan L. Peterson, PhD; Heather M. Maruska, BSc, PharmD(Cand); and John P. Foreyt, PhD
Health Information Technology and Physicians' Knowledge of Drug Costs
Chien-Wen Tseng, MD, MPH; Robert H. Brook, MD, ScD; G. Caleb Alexander, MD, MS; Allen L. Hixon, MD; Emmett B. Keeler, PhD; Carol M. Mangione, MD, MSPH; Randi Chen, MS; Eric A. Jackson, PharmD; and R.
The National Oncology Working Group (NOW) Initiative: Payer and Provider Collaborations in Oncology Benefits Management
Aileen M. Soper, BA; C. E. (Gene) Reeder, RPh, PhD; Loreen M. Brown, MSW; Ana Stojanovska, BS; and Barbara J. Lennert, RN, BSN, MAOM

Low-Value Services in Value-Based Insurance Design

Peter J. Neumann, ScD; Hannah R. Auerbach, BA; Joshua T. Cohen, PhD; and Dan Greenberg, PhD

Building negative incentives into value-based insurance design programs to discourage use of low-value care will involve a number of challenges.

Objectives: To identify potentially low-value services for inclusion in value-based insurance design (VBID) programs and to discuss challenges involved in incorporating such information.

 

Methods: We searched the Tufts Medical Center Cost-Effectiveness Analysis Registry (www.cearegistry.org) to identify examples of low-value services, defined as interventions that make health worse without saving money or those that cost at least $100,000 per quality-adjusted lifeyear gained. We restricted our attention to papers published since 2000. We supplemented this literature review with a list of services recently rejected by the United Kingdom’s National Institute for Health and Clinical Excellence for coverage by the UK’s National Health Service.

 

Results: The list of potentially low-value services includes several drugs to treat cancer, as well as other therapies such as left ventricular assist devices and lung volume reduction surgery. Building negative incentives into VBID programs to discourage use of low-value care will involve a number of challenges, including identification of appropriate candidates; the scope of services to be covered (ie, whether VBID should be expanded beyond drugs to address medical devices, procedures, and diagnostics); and whether VBID programs should target specific subgroups.

 

Conclusion: Identifying noncontroversial low-value services and designing VBID programs to discourage their use will not be easy. However, to fulfill their promise of improving value and moderating cost growth, VBID programs should target low-value as well as high-value care.

 

(Am J Manag Care. 2010;16(4):280-286)



PDF
 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!